Clinic for Oral and Cranio-Maxillofacial Surgery, Hightech Research Center, University Hospital Basel, University of Basel, Basel, Switzerland.
Clinic for Oral and Cranio-Maxillofacial Surgery, Kantonsspital Aarau, Aarau, Switzerland.
Clin Oral Implants Res. 2023 Sep;34 Suppl 26:112-124. doi: 10.1111/clr.14133.
For the present review, the following focused question was addressed: In patients with root-analog dental implants, what is the effect of implants made of other materials than titanium (alloy) on implant survival, marginal bone loss (MBL), and technical and biological complications after at least 5 years.
An electronic (Medline, Embase, Web of Science) search was performed to identify observational clinical studies published from January 2000 investigating a minimum of 20 commercially available zirconia implants with a mean follow-up of at least 60 months. Primary outcome was implant survival, secondary outcomes included peri-implant MBL, probing depths (PDs), and technical and biological complications. Meta-analyses were performed to evaluate implant survival, MBL, and PD.
From 5129 titles, 580 abstracts were selected, and 111 full-text articles were screened. Finally, 4 prospective and 2 retrospective observational clinical cohort studies were included for data extraction. Meta-analyses estimated after 5 years of loading mean values of 97.2% (95% CI 94.7-99.1) for survival (277 implants, 221 patients), 1.1 mm (95% CI: 0.9-1.3) for MBL (229 implants, 173 patients), and 3.0 mm (95% CI 2.5-3.4) for PDs (231 implants, 175 patients).
After 5 years, commercially available zirconia implants showed reliable clinical performance based on survival rates, MBL, and PD values. However, more well-designed prospective clinical studies and randomized clinical trials investigating titanium and zirconia implants are needed to confirm the presently evaluated promising outcomes.
在本综述中,我们关注了以下聚焦问题:对于具有根类似物的牙科植入物患者,使用钛(合金)以外的其他材料制成的植入物对植入物存活率、边缘骨损失(MBL)以及至少 5 年后的技术和生物学并发症有何影响。
进行了电子(Medline、Embase、Web of Science)搜索,以确定从 2000 年 1 月开始至少发表了 20 项关于商业上可用的氧化锆植入物的观察性临床研究,其平均随访时间至少为 60 个月。主要结局是植入物存活率,次要结局包括种植体周围 MBL、探诊深度(PD)和技术及生物学并发症。进行了荟萃分析以评估植入物存活率、MBL 和 PD。
从 5129 个标题中,选择了 580 个摘要,并筛选了 111 篇全文文章。最后,纳入了 4 项前瞻性和 2 项回顾性观察性临床队列研究进行数据提取。荟萃分析估计在 5 年负荷后,存活率的平均值为 97.2%(95%CI 94.7-99.1)(277 个植入物,221 名患者),MBL 为 1.1mm(95%CI:0.9-1.3)(229 个植入物,173 名患者),PD 为 3.0mm(95%CI 2.5-3.4)(231 个植入物,175 名患者)。
在 5 年后,商业上可用的氧化锆植入物具有可靠的临床性能,基于存活率、MBL 和 PD 值。然而,需要更多设计良好的前瞻性临床研究和随机临床试验来证实目前评估的有前景的结果。